Assessing ANXA3 expression at the mRNA level in future studies will be important to determine whether the observed protein-level decreases are also reflected at the transcriptional level, thus strengthening the biological plausibility of ANXA3 as a biomarker of depression severity. This evidence concerns the gene ANXA3 and major depressive disorder.